Yantai Zhenghai Biotechnology Co., Ltd.

SZSE:300653.SZ

27.39 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q22015 Q1
Revenue 107.3788.72290.88997.276115.425109.08191.945109.845113.703117.73299.151100.04698.851102.12877.12181.72389.57744.86178.5368.63571.22561.41650.07460.27258.01847.1850.56648.12647.45636.63443.47536.67141.86828.60830.53430.534
Cost of Revenue 17.9911.38214.2519.13610.63711.14410.4111.38814.17612.88213.74311.3259.9348.5936.9945.8727.4062.5236.7393.355.3833.783.0573.9124.5093.4423.8162.5542.882.3123.2212.5032.9412.1941.9471.947
Gross Profit 89.3877.3476.63888.14104.78897.93681.53598.45799.527104.8585.40888.7288.91693.53470.12775.85182.17142.33771.79165.28565.84357.63647.01756.3653.50943.73746.7545.57244.57634.32240.25434.16838.92826.41428.58728.587
Gross Profit Ratio 0.8320.8720.8430.9060.9080.8980.8870.8960.8750.8910.8610.8870.90.9160.9090.9280.9170.9440.9140.9510.9240.9380.9390.9350.9220.9270.9250.9470.9390.9370.9260.9320.930.9230.9360.936
Reseach & Development Expenses 9.848.2419.19210.85110.60411.82311.06210.0288.8937.56612.7328.3097.5876.5519.1747.175.8754.3546.3455.3325.6414.0784.423.59214.352.89320.7223.4818.639012.71206.03202.8442.844
General & Administrative Expenses -3.0116.167-16.16919.825-2.8726.286-14.28218.522-3.0567.243-9.93715.048-0.2185.856-4.8162.771.7623.467-5.5584.139-0.8044.428-5.5234.239-2.9846.234-19.8397.389-3.4819.139-12.177.5179.5326.055.9385.938
Selling & Marketing Expenses 29.81321.44123.50129.49427.88925.4327.34429.35231.20329.01828.22227.91933.11632.89134.50423.73129.09117.06531.50726.50231.83720.89422.03421.72324.22115.59118.95721.08818.90917.34918.38414.48817.06214.06712.73212.732
SG&A 35.07627.67425.20549.31825.01731.71613.06247.87428.14736.26118.28542.96732.89838.74729.68826.50130.85220.53225.9530.64131.03425.32216.51125.96221.23721.825-0.88228.47715.42926.4886.21422.00526.59320.11718.6718.67
Other Expenses -0.0030-0.26-0.0270.117-0.005-0.914-8.1289.0720.005-1.441-4.7625.9250.03-1.1731.82-0.0862.2110.3740.056-0.0010.1930.0380.0980.013-0.081-1.4821.402-1.091.0063.280.0851.0232.600
Operating Expenses 44.91635.91534.39748.95748.40844.25339.83846.46348.5344.3844.5644.31548.1944.96148.54232.39941.48725.02445.27735.19641.21329.39729.85929.67434.73521.76522.56328.82230.59626.78727.97322.14826.75620.22918.14518.145
Operating Income 44.46441.42542.24143.7862.16162.85735.86555.60555.92964.67346.91148.66544.32351.92724.70446.12942.21920.6630.12733.70727.95331.7122.38729.75121.33925.928.38119.29414.8658.06513.05612.71112.3676.5039.6249.624
Operating Income Ratio 0.4140.4670.4650.450.5390.5760.390.5060.4920.5490.4730.4860.4480.5080.320.5640.4710.4610.3840.4910.3920.5160.4470.4940.3680.5490.5610.4010.3130.220.30.3470.2950.2270.3150.315
Total Other Income Expenses Net 6.1096.5727.272-0.0270.117-0.005-0.9140.5450.3990.005-1.4411.1470.0160.03-1.1731.82-0.0862.2110.3740.056-0.0010.1930.0380.0980.013-0.081-1.4661.3940.4481.0065.3430.0511.0132.60.9230.923
Income Before Tax 50.57347.99849.51343.75362.27962.85134.95156.1556.32864.67945.4749.81244.33951.95823.53147.94842.13322.87130.50133.76327.95231.90322.42529.84821.35225.81926.91520.68815.3139.07118.39912.76213.389.10210.54610.546
Income Before Tax Ratio 0.4710.5410.5450.450.540.5760.380.5110.4950.5490.4590.4980.4490.5090.3050.5870.470.510.3880.4920.3920.5190.4480.4950.3680.5470.5320.430.3230.2480.4230.3480.320.3180.3450.345
Income Tax Expense 4.9227.6166.895.265.8369.4534.8684.8817.2649.6593.3614.4577.2427.9650.5277.6346.5333.4552.7275.1414.0094.8551.7624.6733.2583.9363.8982.9232.2051.2912.6512.062.0711.3921.5081.508
Net Income 45.65140.38142.62238.49356.44353.39930.08451.26949.06455.0242.10945.35537.09643.99323.00440.31435.619.41627.77428.62223.94327.04820.66325.17518.09421.88323.01717.76513.1087.7815.74810.70211.3097.7119.0389.038
Net Income Ratio 0.4250.4550.4690.3960.4890.490.3270.4670.4320.4670.4250.4530.3750.4310.2980.4930.3970.4330.3540.4170.3360.440.4130.4180.3120.4640.4550.3690.2760.2120.3620.2920.270.270.2960.296
EPS 0.250.220.240.210.320.30.420.280.270.310.230.250.210.250.130.230.20.110.150.160.140.150.120.140.10.120.130.0980.0870.0580.110.080.0850.0570.0670.067
EPS Diluted 0.250.220.240.210.310.30.420.280.270.310.230.250.210.250.130.230.20.110.150.160.140.150.120.140.10.120.130.0980.0870.0580.110.080.0850.0570.0670.067
EBITDA 50.02143.88847.56940.09951.69451.75664.66139.9354.97956.5134.9534.743.47745.84414.70543.81540.66517.41526.79230.12224.53428.3431.18226.77519.23321.9431.50516.86513.987.53523.31112.05412.1726.1849.8469.846
EBITDA Ratio 0.4660.4950.5230.4120.4480.4740.7030.3640.4840.480.3520.3470.440.4490.1910.5360.4540.3880.3410.4390.3440.4610.6230.4440.3320.4650.6230.350.2950.2060.5360.3290.2910.2160.3220.322